These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 30543891

  • 1. Challenging identification of polymorphic mixture: Polymorphs I, II and III in olanzapine raw materials.
    Testa CG, Prado LD, Costa RN, Costa ML, Linck YG, Monti GA, Cuffini SL, Rocha HVA.
    Int J Pharm; 2019 Feb 10; 556():125-135. PubMed ID: 30543891
    [Abstract] [Full Text] [Related]

  • 2. A Simultaneous Differential Scanning Calorimetry-X-ray Diffraction Study of Olanzapine Crystallization from Amorphous Solid Dispersions.
    Askin S, Gonçalves AD, Zhao M, Williams GR, Gaisford S, Craig DQM.
    Mol Pharm; 2020 Nov 02; 17(11):4364-4374. PubMed ID: 33074007
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. New applications of electron diffraction in the pharmaceutical industry: polymorph determination by using a combination of electron diffraction and synchrotron X-ray powder diffraction techniques.
    Li ZG, Harlow RL, Foris CM, Li H, Ma P, Vickery RD, Maurin MB, Toby BH.
    Microsc Microanal; 2002 Apr 02; 8(2):134-8. PubMed ID: 12533242
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study.
    Araya-Sibaja AM, Paulino AS, Rauber GS, Campos CE, Cardoso SG, Monti GA, Heredia V, Bianco I, Beltrano D, Cuffini SL.
    Pharm Dev Technol; 2014 Nov 02; 19(7):779-88. PubMed ID: 24032356
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemometrics-assisted solid-state characterization of pharmaceutically relevant materials. Polymorphic substances.
    Calvo NL, Maggio RM, Kaufman TS.
    J Pharm Biomed Anal; 2018 Jan 05; 147():518-537. PubMed ID: 28668295
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state (13)C CPMAS NMR spectroscopy.
    Virtanen T, Maunu SL.
    Int J Pharm; 2010 Jul 15; 394(1-2):18-25. PubMed ID: 20416365
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Quantification of olanzapine polymorphs using powder X-ray diffraction technique.
    Tiwari M, Chawla G, Bansal AK.
    J Pharm Biomed Anal; 2007 Feb 19; 43(3):865-72. PubMed ID: 17034979
    [Abstract] [Full Text] [Related]

  • 17. Exploring solid forms of oxytetracycline hydrochloride.
    Bueno MS, Miñambres GG, Bongioanni A, Chattah AK, Aiassa V, Longhi MR, Garnero C.
    Int J Pharm; 2020 Jul 30; 585():119496. PubMed ID: 32504775
    [Abstract] [Full Text] [Related]

  • 18. [Advances in the quantitative analytical methods of drug polymorphism].
    Ma LW, Du W, Zhao CS.
    Yao Xue Xue Bao; 2011 Aug 30; 46(8):896-903. PubMed ID: 22007512
    [Abstract] [Full Text] [Related]

  • 19. Olanzapine solvates.
    Cavallari C, Santos BP, Fini A.
    J Pharm Sci; 2013 Nov 30; 102(11):4046-56. PubMed ID: 23963777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.